Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.1100-0.1600 (-3.75%)
At close: 04:00PM EDT
3.9500 -0.16 (-3.89%)
After hours: 07:37PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/11/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
164.80M67.77M20.22M30.24M47.38M
Enterprise Value
149.87M45.57M5.40M8.26M20.14M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
15.753.971.961.712.04
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-4.73-6.49-0.69-1.17-2.12

Trading Information

Stock Price History

Beta (5Y Monthly) 0.21
52-Week Change 3111.91%
S&P500 52-Week Change 3-5.84%
52 Week High 34.6830
52 Week Low 30.4600
50-Day Moving Average 33.0646
200-Day Moving Average 31.8342

Share Statistics

Avg Vol (3 month) 31.47M
Avg Vol (10 day) 3379.35k
Shares Outstanding 538.69M
Implied Shares Outstanding 6N/A
Float 814.02M
% Held by Insiders 15.52%
% Held by Institutions 162.20%
Shares Short (Jul 28, 2022) 4138.75k
Short Ratio (Jul 28, 2022) 40.04
Short % of Float (Jul 28, 2022) 40.64%
Short % of Shares Outstanding (Jul 28, 2022) 40.36%
Shares Short (prior month Jun 29, 2022) 499.36k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-53.60%
Return on Equity (ttm)-192.68%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.36M
Net Income Avi to Common (ttm)-32.9M
Diluted EPS (ttm)-1.2810
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.11M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)14.18M
Total Debt/Equity (mrq)135.52
Current Ratio (mrq)2.32
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)-28.46M
Levered Free Cash Flow (ttm)-16.21M
Advertisement
Advertisement